What Dahlia Consulting does

Dahlia Consulting is a privately held, Chicago-based professional services consulting firm founded in 2014 that serves the global life sciences industry with a narrow but deep specialization in cell and gene therapy, biologics, biosimilars, and pharmaceutical manufacturing. The firm positions itself as an embedded partner to clients rather than a transactional advisor, with a team of seasoned consultants delivering the full cell and gene therapy product lifecycle from facility design through commercial launch.

Its service offering is structured as ten integrated modules — Design & Construction Management, Operational Readiness, Business Operations, Quality Compliance & Regulatory, Manufacturing & Supply Chain, Information Technology & Security, Market Access, Leadership & Coaching, Resource Augmentation, and Product Commercialization Strategy — allowing the firm to staff engagements across R&D, CMC, regulatory, manufacturing, supply chain, and commercial workstreams. Underlying technology is limited; the core "platform" is the consulting bench and its accumulated domain expertise rather than a proprietary software product.

Dahlia generates revenue through professional services engagements priced on a quote basis, with multi-year contract cadences typical for enterprise clients. Go-to-market is direct enterprise field sales into pharmaceutical manufacturers, biotechs, CDMOs, and medical device companies, supplemented by affiliate partnerships with Jeff Yuen & Associates and Pharmefex that extend regulatory, CMC, and process development coverage. The firm is bootstrapped (no external funding), employs 11–50 people, and maintains a horizontal segmentation approach across pharma, biotech, medical device, and dermatology end markets.

Name

Dahlia Consulting

Legal name

Dahlia Consulting

Website

https://dahlia-consulting.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Dahlia Consulting is a privately held, Chicago-based boutique consulting firm founded in 2014 that delivers embedded cell and gene therapy, biologics, and pharmaceutical manufacturing advisory services to enterprise pharma, biotech, CDMO, and medical device clients across the full product lifecycle.

Ownership category

akta.pro rank

Product category

Pharmaceutical Consulting Services

NAICS

Management Consulting Services (54161), Administrative Management and General Management Consulting Services (541611)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Strategy & Corporate Development Consulting (BPAHACAA)

akta.pro secondary industries

Innovation, Product & R&D Consulting (BPAHACAM), Corporate Strategy Advisory (BPAHADAA)

Keywords

• Pharmaceutical consulting services
• Cell and gene therapy consulting
• Biotech regulatory compliance
• Pharmaceutical manufacturing consulting
• Life sciences advisory

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Professional Consulting Services: Dahlia Consulting provides expert consulting services to pharmaceutical manufacturers, biotech companies, and life sciences organizations. Services span strategic advisory, operational readiness, quality compliance, regulatory affairs, design and construction management, manufacturing support, IT security, market access, leadership coaching, resource augmentation, and product commercialization. Revenue is generated through professional service engagements with enterprise clients.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Dahlia Consulting is a professional services firm that provides strategic and operational consulting to pharmaceutical manufacturers, biotech companies, and life sciences organizations, with deep specialization in cell and gene therapy. The firm sells discrete consulting service modules spanning facility design and construction management, operational readiness, business operations, quality compliance and regulatory affairs, manufacturing and supply chain, IT and security, market access, leadership coaching, resource/staffing augmentation, and product commercialization strategy. Engagements are delivered by embedded consultants who act as an extension of the client's team across the full product lifecycle.

Product overview

Dahlia Consulting is a strategic consulting firm offering integrated services to the global life sciences industry, specializing in cell and gene therapy, biologics, and biosimilars. The company provides a comprehensive suite of consulting service modules including Design & Construction Management, Operational Readiness, Business Operations, Quality Compliance & Regulatory, Manufacturing & Supply Chain, Information Technology & Security, Market Access, Leadership & Coaching, Resource Augmentation, and Product Commercialization Strategy. These services work together as an integrated consulting framework, supporting pharmaceutical manufacturers from facility design and operational setup through regulatory compliance, manufacturing optimization, and commercial launch.

Differentiator

Problem solved

Functional benefit

Products and services

• Cell and Gene Therapy Consulting Services Overall strategic consulting services for pharmaceutical manufacturers and biotech companies developing cell and gene therapies. Covers facility design, operational readiness, regulatory compliance, manufacturing, market access, and commercialization support across the full product lifecycle. Targeted at enterprise pharmaceutical and life sciences clients.
• Design & Construction Management Consulting service covering project planning, site selection, budgeting, permitting, construction oversight, and facility commissioning for biopharmaceutical facilities. For pharmaceutical and biotech clients building or expanding manufacturing capabilities.
• Operational Readiness Consulting service for facility operational readiness, governance design, integrated project planning, equipment qualification, tech transfer, and environmental monitoring performance qualification (EMPQ). Supports pharmaceutical clients preparing facilities for validated operation.
• Business Operations Consulting service providing business operations assessment, PMO establishment, organizational design, operational excellence, and capabilities and operating model design. Targeted at cell and gene therapy companies building operational maturity.
• Quality Compliance & Regulatory Consulting service covering CMC IND/BLA roadmap strategy, quality control and analytical development, quality systems, quality operations, regulatory inspection preparation, vendor audits, quality agreements, and interim leadership. For pharmaceutical manufacturers managing regulatory submissions and audits.
• Manufacturing & Supply Chain Consulting service covering master batch records design, enterprise business systems implementation (MES, SAP), CDMO support, production management, capacity modeling, and supply chain strategy. For pharmaceutical and cell and gene therapy manufacturers optimizing production operations.
• Information Technology & Security Consulting service providing CIO advisory services, IT strategy roadmap, IT security roadmap, technology budget forecasting, IT governance alignment, vendor selection, and technology negotiation support. For pharmaceutical IT and security leaders.
• Market Access Consulting service developing value and access strategy to optimize asset value, healthcare provider preference, and patient access for pharmaceutical and cell and gene therapy manufacturers launching products in the market.
• Leadership & Coaching Custom-tailored leadership development programs for pharmaceutical and biotech professionals to identify and develop executive capabilities. Targeted at leaders in pharmaceutical companies and life sciences start-ups.
• Resource Augmentation Hand-picked talent placement service providing permanent and contract staffing solutions for pharmaceutical and biotech companies. Targets life sciences clients needing specialized talent in cell and gene therapy, regulatory, and manufacturing.
• Product Commercialization Strategy Embedded consulting service supporting product commercialization from tech transfer through commercial launch. Covers process/manufacturing technical services, regulatory, clinical, patient operations, manufacturing, supply chain, quality compliance, and program management for cell and gene therapy products.

Named customers24 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• Jeff Yuen & AssociatescoreStrategic or Co-development PartnerJeff Yuen & Associates provides comprehensive consulting services for pharmaceutical phases including pre-clinical, clinical, and commercial operations, testing, and regulatory support. Services include audit facilitation, gap assessments, mock inspections, facility design reviews, qualified person services (UK-based), qualification and validation review, due diligence for mergers/acquisitions, data integrity assessments, technical support, CMC regulatory support, vendor audits, and back room inspection management.
• PharmefexcoreStrategic or Co-development PartnerPharmefex Consulting, founded in 2014 and headquartered in Bellevue Washington, provides expert technical, regulatory, and compliance services to clients worldwide. Specializes in streamlining process development, accelerating time to market, reducing cost of goods, managing technology transfers, preparing CMC submissions, and resolving manufacturing and compliance problems for recombinant proteins and cellular immunotherapy products. Hands-on experience with development, transfer, validation, and manufacturing of cellular immunotherapy products sets them apart.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• West Monroe Partners: Management and technology consulting firm with a healthcare and life sciences practice covering operations, M&A, and technology-enabled transformation. Competes with Dahlia for pharmaceutical and biotech operations, IT, and transformation work.
• Navigant (now part of Guidehouse): Global consulting firm with a life sciences segment offering regulatory, compliance, and operational strategy to pharma and biotech. Direct overlap with Dahlia's Quality Compliance & Regulatory and Operational Readiness services at larger enterprise scale.
• Slalom Consulting: Large technology and management consulting firm with a strong life sciences practice serving pharma, biotech, and medical device companies. Provides IT, transformation, and operational support that overlaps with Dahlia's IT & Security and Business Operations modules.
• Charles River Associates: Global consulting firm with a life sciences practice providing strategy, economics, and regulatory advisory. A scaled incumbent competing for similar pharma/biotech advisory work, with much broader scope but a relevant life sciences presence.

Direct peers

• Clarkston Consulting: Management consulting firm with a dedicated life sciences practice serving pharma, biotech, and medical device clients on operations, regulatory, supply chain, and commercial strategy. Comparable to Dahlia in services, target customers, and B2B consulting model.
• Trinity Life Sciences: Life sciences consultancy offering commercial, market access, and evidence-based strategy support to pharma and biotech. Overlaps with Dahlia's Market Access and Product Commercialization Strategy modules and serves similar enterprise pharma clients.
• Latham BioPharm Group: Specialist life sciences consulting firm focused on biopharmaceutical strategy, CMC, regulatory, and manufacturing support. Closely comparable to Dahlia in service scope (CMC, regulatory, quality) and client base (biopharma manufacturers), and a direct competitor for cell and gene therapy engagements.
• Beghou Consulting: Life sciences commercial consulting firm focused on sales, marketing, and market access analytics for pharma and biotech. Comparable to Dahlia's Market Access and Product Commercialization Strategy capabilities with similar B2B professional services delivery.
• Pharmefex Consulting: Cellular immunotherapy and recombinant protein consulting firm offering CMC, regulatory, and process development support. Listed as a Dahlia affiliate, indicating tightly overlapping capabilities and direct peer status in cell therapy consulting.

Emerging players

• Navint Partners: Specialized life sciences and healthcare consulting firm providing commercial strategy, market access, and operations support. Smaller-than-incumbent but comparable in scope to Dahlia's market access and commercial services, with overlap in target customer profile.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/dahlia-consulting

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dahlia Consulting